1.World Health Organization (2009) Mortality and Burden of Disease Estimates for WHO Member States in 2004. Geneva: WHO.
2. H King & M Rewers (1993) Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes Care 16, 157–177.
3. J Shaw , RA Sicree & PZ Zimmet (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87, 4–14.
4. R Sicree , J Shaw & P Zimme (2010) Diabetes and Impaired Glucose Tolerance. Geneva: IDF.
5. C Murray & AD Lopez (1996) Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard School of Public Health.
6. AM Prentice (2006) The emerging epidemic of obesity in developing countries. Int J Epidemiol 35, 93–99.
7. P Hossain , B Kawar & M El Nahas (2007) Obesity and diabetes in the developing world – a growing challenge. N Engl J Med 356, 213–215.
8. JC Seidell (2000) Obesity, insulin resistance and diabetes – a worldwide epidemic. Br J Nutr 83, Suppl. 1, S5–S8.
9. R Simmons , N Unwin & S Griffin (2010) An Update of the Evidence Concerning the Prevention of Type 2 Diabetes. Geneva: IDF.
10. A Ramachandran , C Snehalatha , S Mary et al. (1997) The Indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49, 289–297.
11. K Brownell , T Farley , WC Willett et al. (2009) The public health and economic benefits of taxing sugar-sweetened beverages. N Engl J Med 361, 1599–1605.
12. K Brownell & TR Frieden (2009) Ounces of prevention – the public policy case for taxes on sugared beverages. N Engl J Med 360, 1805–1808.
13. J Salmeron , JE Manson , MJ Stampfer et al. (1997) Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 277, 472–477.
14. J Salmeron , A Ascherio , EB Rimm et al. (1997) Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 20, 545–550.
15. DS Ludwig (2002) The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 287, 2414–2423.
16. DM Mourao , J Bressan , WW Campbell et al. (2007) Effects of food form on appetite and energy intake in lean and obese young adults. Int J Obes (Lond) 31, 1688–1695.
17. MB Schulze , JE Manson , DS Ludwig et al. (2004) Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 292, 927–934.
18. SS Elliott , NL Keim , JS Stern et al. (2002) Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 76, 911–922.
19. GA Bray (2007) How bad is fructose? Am J Clin Nutr 86, 895–896.
20. M Yoshida , NM McKeown , G Rogers et al. (2007) Surrogate markers of insulin resistance are associated with consumption of sugar-sweetened drinks and fruit juice in middle and older-aged adults. J Nutr 137, 2121–2127.
21. G Roglic & N Unwin (2005) Global mortality attributable to diabetes: time for a realistic estimates. Diabetes Voice 50, 33–34.
22. W Yang , J Lu , W Jia et al. (2010) Prevalence of diabetes among men and women in China. N Engl J Med 362, 1090–1101.
23. J Diamond (2011) Medicine: diabetes in India. Nature 469, 478–479.
24. A Ramachandran , S Mary , A Yamuna et al. (2008) High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India. Diabetes Care 31, 893–898.
25. H King , RE Aubert & WM Herman (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21, 1414–1431.
26. S Yusuf , S Reddy , S Ounpuu et al. (2001) Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104, 2746–2753.
27. A Drewnowski & BM Popkin (1997) The nutrition transition: new trends in the global diet. Nutr Rev 55, 31–43.
28. KS Reddy & S Yusuf (1998) Emerging epidemic of cardiovascular disease in developing countries. Circulation 97, 596–601.
29. CA Monteiro , EC Moura , WL Conde et al. (2004) Socioeconomic status and obesity in adult populations of developing countries: a review. Bull World Health Organ 82, 940–946.
30. K Brownell & KE Warner (2009) The perils of ignoring history: Big Tobacco played dirty and millions died. How similar is Big Food? Milbank Q 87, 259–294.
31. D Stuckler (2008) Population causes and consequences of leading chronic diseases: a comparative analysis of prevailing explanations. Milbank Q 86, 273–326.
33.Food and Agriculture Organization of the United Nations (2011) FAOSTAT Statistical Database. Rome: FAO.
34. AS Fauci (2008) Diabetes mellitus. In Harrison’'s Principles of Internal Medicine, Chapter 344. New York: McGraw-Hill.
35.World Bank (2011) World Development Indicators Database. Washington, DC: IBRD.
36. G Danaei , MM Finucane , Y Lu et al. (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378, 31–40.
37. P Zhang , X Zhang , JB Brown et al. (2010) Economic Impact of Diabetes. Geneva: IDF.
38. B Popkin (2002) What is unique about the experience in lower- and middle-income less-industrialised countries compared with the very-high income countries? The shift in the stages of the nutrition transition differs from past experiences! Public Health Nutr 5, 205–214.
39. KS Reddy (2002) Cardiovascular diseases in the developing countries: dimensions, determinants, dynamics and directions for public health action. Public Health Nutr 5, 231–237.